http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107722035-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca5765144d5946338fdb419012358cb5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29bd7887dcadcc964bd7035dd01b19fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63cd6674132e5d1abe9473b847989a2f
publicationDate 2018-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107722035-A
titleOfInvention A class of artemisinin-piperazine derivatives and its preparation method and application in the preparation of anti-liver cancer drugs
abstract The invention discloses a class of artemisinin-piperazine derivatives, a preparation method thereof and the application of the derivatives in the preparation of anti-liver cancer drugs. The method uses triethylamine as an acid-binding agent to prepare artemisinin-piperazine derivatives through a "one-pot method". The reaction conditions are mild, the operation is simple, and the yield is good. In addition, the prepared derivatives have obvious inhibitory effect on human liver cancer SMMC‑7721 cells in vitro, which is equivalent to the inhibitory effect of vincristine, a first-line anti-hepatic cancer clinical chemotherapy drug. The present invention provides a feasible strategy for the application of artemisinin-piperazine derivatives in the preparation of anti-liver cancer drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112707917-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110922414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114621161-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114621161-A
priorityDate 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102153564-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015216888-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465395328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410625406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148253921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163728109

Total number of triples: 23.